BioPharma Dive January 13, 2025
Ben Fidler, Delilah Alvarado and Gwendolyn Wu

Security was tight for the first day of the J.P. Morgan Healthcare Conference, which featured major M&A as well as presentations from several large pharmas.

Every January, the Westin St. Francis in San Francisco is, for a few days, the center of the universe for the healthcare industry. It’s the site of the J.P. Morgan Healthcare Conference, where hundreds of companies pitch investors, negotiate deals and plan for the year ahead.

The convergence of thousands of executives in one location makes the meeting a good barometer for the industry’s mood. But in the wake of the recent killing of United Healthcare CEO Brian Thompson, this year’s conference began with a dose of tension — and extra security.

While J.P. Morgan...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
AI empathy is a good fit for behavioral and mental healthcare
Live from AONL 2025: 3 Major Concerns for CNOs
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
Podcast: Meena Seshamani on the Journey from CMS to Maryland's Department of Health
Pivot: Discussing the Impact of a Proposed HIPAA Security Update

Share This Article